selected publications
- Effect of total gastrectomy on weight and body composition: A retrospective study. Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition. 2026 Academic Article GET IT
- ASO Visual Abstract: Long-Term Oncologic Outcomes Following Pathologic Complete Response for Esophageal Cancer. Annals of surgical oncology. 2026 Academic Article GET IT
-
Circulating tumor DNA informs clinical practice in patients with recurrent/metastatic gastroesophageal cancers.
Cancer.
2026
Academic Article
GET IT
Times cited: 1 - A phase II study of trifluridine/tipiracil in combination with ramucirumab in advanced, refractory gastric, or gastroesophageal junction adenocarcinomas. The oncologist. 2025 Academic Article GET IT
-
Long-term Oncologic Outcomes Following Pathologic Complete Response for Esophageal Cancer.
Annals of surgical oncology.
2025
Academic Article
GET IT
Times cited: 1 -
Survival after esophagectomy for metastatic esophageal cancer: should the role of surgery be reconsidered?.
Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract.
2025
Academic Article
GET IT
Times cited: 1 -
Zanidatamab plus chemotherapy as first-line treatment for patients with HER2-positive advanced gastro-oesophageal adenocarcinoma: primary results of a multicentre, single-arm, phase 2 study.
The Lancet. Oncology.
2025
Academic Article
GET IT
Times cited: 18 -
Biomarker-Driven Approach to the Treatment of Metastatic Gastric or Gastroesophageal Adenocarcinoma.
Journal of the National Comprehensive Cancer Network : JNCCN.
2025
Information Resource
GET IT
Times cited: 4 -
Detecting Early Recurrence With Circulating Tumor DNA in Stage I-III Biliary Tract Cancer After Curative Resection.
JCO precision oncology.
2025
Academic Article
GET IT
Times cited: 8 -
Evaluating Debio 1347 in Patients with FGFR Fusion-Positive Advanced Solid Tumors from the FUZE Multicenter, Open-Label, Phase II Basket Trial.
Clinical cancer research : an official journal of the American Association for Cancer Research.
2024
Academic Article
GET IT
Times cited: 10 -
Clinical and Pathologic Response to Neoadjuvant Immunotherapy in DNA Mismatch Repair Protein-Deficient Gastroesophageal Cancers.
Annals of surgical oncology.
2024
Academic Article
GET IT
Times cited: 6 -
Intra-operative pyloric BOTOX injection versus pyloric surgery for prevention of delayed gastric emptying after esophagectomy.
Surgical endoscopy.
2024
Academic Article
GET IT
Times cited: 6 -
Circulating tumor DNA molecular analyses and real-world evidence outcomes of FGFR2 amplified gastroesophageal cancers.
The oncologist.
2024
Academic Article
GET IT
Times cited: 1 -
Totally minimally invasive laparoscopic robot-assisted Ivor Lewis esophagectomy: improved technique and outcomes over 200 cases.
Journal of gastrointestinal oncology.
2024
Academic Article
GET IT
Times cited: 1 -
Initial Experience Using Laparoscopic HIPEC for Gastric Cancer with Peritoneal Metastasis: Safety and Outcomes.
Annals of surgical oncology.
2024
Academic Article
GET IT
Times cited: 8 -
Biomarker Analysis from a Phase I/Ib Study of Regorafenib and Nivolumab in Mismatch Repair-Proficient Advanced Refractory Colorectal Cancer.
Cancers.
2024
Academic Article
GET IT
Times cited: 3 -
RNA Expression-Based Analysis to Predict Response in Patients with Metastatic Mismatch Repair Proficient Colorectal Cancer Treated with Regorafenib and Nivolumab.
Oncology.
2023
Academic Article
GET IT
Times cited: 2 - Locally advanced mismatch repair-deficient gastroesophageal junction cancer: Diagnosis, treatment modifications, and monitoring. CA: a cancer journal for clinicians. 2023 Article GET IT
-
Induction Fluorouracil-Based Chemotherapy and PET-Adapted Consolidation Chemoradiation with Esophagectomy for High-Risk Gastroesophageal Adenocarcinoma.
Cancers.
2023
Academic Article
GET IT
Times cited: 1 -
FLOT or CROSS for gastroesophageal junction cancers-is the debate over yet?.
Chinese clinical oncology.
2023
Information Resource
GET IT
Times cited: 1 -
Tumor Regression Grade and Overall Survival following Gastrectomy with Preoperative Therapy for Gastric Cancer.
Annals of surgical oncology.
2023
Academic Article
GET IT
Times cited: 23 -
Real-World Molecular Biomarker Testing Patterns and Results for Advanced Gastroesophageal Cancers in the United States.
Current oncology (Toronto, Ont.).
2023
Academic Article
GET IT
Times cited: 3 -
Immunotherapy and Targeted Therapy for Advanced Gastroesophageal Cancer: ASCO Guideline.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
2023
Information Resource
GET IT
Times cited: 179 -
Nivolumab plus chemotherapy in patients with HER2-negative, untreated, unresectable advanced or recurrent gastric or gastroesophageal junction cancer-regional differences in efficacy.
Annals of palliative medicine.
2022
Editorial Article
GET IT
Times cited: 2 -
Phase I Study of Lenvatinib and Capecitabine with External Radiation Therapy in Locally Advanced Rectal Adenocarcinoma.
The oncologist.
2022
Academic Article
GET IT
Times cited: 3 - The effect of histologic grade on neoadjuvant treatment outcomes in esophageal cancer. Journal of surgical oncology. 2022 Academic Article GET IT
-
A phase I/Ib study of regorafenib and nivolumab in mismatch repair proficient advanced refractory colorectal cancer.
European journal of cancer (Oxford, England : 1990).
2022
Academic Article
GET IT
Times cited: 71 -
Evaluation of Tumor DNA Sequencing Results in Patients with Gastric and Gastroesophageal Junction Adenocarcinoma Stratified by TP53 Mutation Status.
The oncologist.
2022
Academic Article
GET IT
Times cited: 5 -
Chemotherapy Versus Chemotherapy Plus Chemoradiation as Neoadjuvant Therapy for Resectable Gastric Adenocarcinoma: A Multi-institutional Analysis.
Annals of surgery.
2021
Academic Article
GET IT
Times cited: 22 -
Impact of histology classification on pathologic treatment response and overall survival in distal esophageal cancer patients: a propensity matched analysis.
Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.
2021
Academic Article
GET IT
Times cited: 4 -
A phase 1/2 trial of ibrutinib in combination with pembrolizumab in patients with mismatch repair proficient metastatic colorectal cancer.
British journal of cancer.
2021
Academic Article
GET IT
Times cited: 34 -
Investigational PARP inhibitors for the treatment of biliary tract cancer: spotlight on preclinical and clinical studies.
Expert opinion on investigational drugs.
2021
Information Resource
GET IT
Times cited: 8 -
Phase 2 study of copanlisib in combination with gemcitabine and cisplatin in advanced biliary tract cancers.
Cancer.
2020
Academic Article
GET IT
Times cited: 34 -
Pretreatment CT and 18 F-FDG PET-based radiomic model predicting pathological complete response and loco-regional control following neoadjuvant chemoradiation in oesophageal cancer.
Journal of medical imaging and radiation oncology.
2020
Academic Article
GET IT
Times cited: 27 -
Outcomes of 350 Robotic-assisted Esophagectomies at a High-volume Cancer Center: A Contemporary Propensity-score Matched Analysis.
Annals of surgery.
2020
Academic Article
GET IT
Times cited: 25 -
Rare Abdominal Wall Metastasis following Curative Resection of Gastric Cancer: What Can Be Learned from the Use of Percutaneous Catheters?.
Case reports in oncological medicine.
2020
Article
GET IT
Times cited: 17 -
Outcomes of Gastric Resection in the Establishment of a Comprehensive Oncologic Robotic Program.
The Journal of surgical research.
2020
Academic Article
GET IT
Times cited: 2 -
Clinical Factors and Outcomes of Octogenarians Receiving Curative Surgery for Esophageal Cancer.
The Journal of surgical research.
2020
Academic Article
GET IT
Times cited: 11 -
Clinical factors associated with the development of postoperative atrial fibrillation in esophageal cancer patients receiving multimodality therapy before surgery.
Journal of gastrointestinal oncology.
2020
Academic Article
GET IT
Times cited: 14 -
Radiation-induced hepatitis masquerading as metastatic disease: the importance of correlating diagnostic imaging with treatment planning.
Journal of gastrointestinal oncology.
2020
Article
GET IT
Times cited: 3 -
The Impact of Ramucirumab Treatment on Survival and Quality of Life in Patients with Gastric Cancer.
Cancer management and research.
2020
Information Resource
GET IT
Times cited: 16 -
An open-label, single-arm pilot study of EUS-guided brachytherapy with phosphorus-32 microparticles in combination with gemcitabine +/- nab-paclitaxel in unresectable locally advanced pancreatic cancer (OncoPaC-1): Technical details and study protocol.
Endoscopic ultrasound.
2020
Academic Article
GET IT
Times cited: 27 -
Prioritization of Therapy Options for a Patient With High Tumor Mutation Burden and Microsatellite Instability but No Clinical Benefit From Immunotherapy.
JCO precision oncology.
2019
Article
GET IT
Times cited: 1 -
Is Preoperative G-Tube Use Safe for Esophageal Cancer Patients?.
Journal of the American College of Nutrition.
2019
Academic Article
GET IT
Times cited: 6 -
Predictive markers in gastric cancer immunotherapy treatment-are we there yet?.
Translational gastroenterology and hepatology.
2019
Editorial Article
GET IT
Times cited: 3 -
Clinical characterization of colitis arising from anti-PD-1 based therapy.
Oncoimmunology.
2018
Academic Article
GET IT
Times cited: 58 -
Pembrolizumab for the treatment of patients with recurrent locally advanced or metastatic gastric or gastroesophageal junction cancer: an evidence-based review of place in therapy.
OncoTargets and therapy.
2018
Information Resource
GET IT
Times cited: 8 -
Patterns of Long-term Cancer Survivorship Care in a National Cancer Institute-Designated Comprehensive Cancer Center.
American journal of clinical oncology.
2017
Academic Article
GET IT
Times cited: 5 -
A Rare Case of S310F Somatic ERBB2 Mutation in a HER2-Nonamplified Breast Cancer.
Clinical breast cancer.
2016
Article
GET IT
Times cited: 16 -
Cerebral fat embolism syndrome mimicking thrombotic thrombocytopenic purpura in a patient with hemoglobin SC disease.
American journal of hematology.
2016
Article
GET IT
Times cited: 20 -
Cancer Survivorship and Models of Survivorship Care: A Review.
American journal of clinical oncology.
2015
Information Resource
GET IT
Times cited: 45 -
Gene Expression Analysis Reveals Distinct Pathways of Resistance to Bevacizumab in Xenograft Models of Human ER-Positive Breast Cancer.
Journal of Cancer.
2014
Academic Article
GET IT
Times cited: 9 -
Thrombophilia testing in children: a 7 year experience.
Pediatric blood & cancer.
2013
Academic Article
GET IT
Times cited: 9 -
Investigational drug MLN0128, a novel TORC1/2 inhibitor, demonstrates potent oral antitumor activity in human breast cancer xenograft models.
Breast cancer research and treatment.
2012
Academic Article
GET IT
Times cited: 75 -
Extrathoracic metastases of thymic origin: a review of 35 cases.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.
2011
Academic Article
GET IT
Times cited: 58 -
PHLDA1 is a crucial negative regulator and effector of Aurora A kinase in breast cancer.
Journal of cell science.
2011
Academic Article
GET IT
Times cited: 66 -
Atypical ductal hyperplasia: interobserver and intraobserver variability.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.
2011
Academic Article
GET IT
Times cited: 110 -
FOXA1 is an independent prognostic marker for ER-positive breast cancer.
Breast cancer research and treatment.
2011
Academic Article
GET IT
Times cited: 106 -
High-level expression of forkhead-box protein A1 in metastatic prostate cancer.
Histopathology.
2011
Academic Article
GET IT
Times cited: 62 -
Personalized medicine: the road ahead.
Clinical breast cancer.
2011
Information Resource
GET IT
Times cited: 40 -
Control of EVI-1 oncogene expression in metastatic breast cancer cells through microRNA miR-22.
Oncogene.
2010
Academic Article
GET IT
Times cited: 114 -
Loss of ERα and FOXA1 expression in a progression model of luminal type breast cancer: insights from PyMT transgenic mouse model.
Oncology reports.
2010
Academic Article
GET IT
Times cited: 23 -
WHO types A and AB thymomas: not always benign.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.
2010
Academic Article
GET IT
Times cited: 45 -
ITF2 is a target of CXCR4 in MDA-MB-231 breast cancer cells and is associated with reduced survival in estrogen receptor-negative breast cancer.
Cancer biology & therapy.
2010
Academic Article
GET IT
Times cited: 14 -
Expression of high-molecular-weight cytokeratin (34betaE12) is an independent predictor of disease-free survival in patients with triple-negative tumours of the breast.
Journal of clinical pathology.
2010
Academic Article
GET IT
Times cited: 10 -
Genomic and immunohistochemical analysis of adenosquamous carcinoma of the breast.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.
2010
Academic Article
GET IT
Times cited: 57 -
Conjunctival squamous cell carcinoma due to ocular prostheses: a case report and review of literature.
Pathology oncology research : POR.
2010
Article
GET IT
Times cited: 11 -
Differential subcellular expression of protein kinase C betaII in breast cancer: correlation with breast cancer subtypes.
Breast cancer research and treatment.
2010
Academic Article
GET IT
Times cited: 16 -
Prognostic impact of ALDH1 in breast cancer: a story of stem cells and tumor microenvironment.
Breast cancer research and treatment.
2009
Academic Article
GET IT
Times cited: 162